Novel association strategy with copy number variation for identifying new risk Loci of human diseases.

Novel association strategy with copy number variation for identifying new risk Loci of human diseases.
复制标题

DOI:
10.1371/journal.pone.0012185
复制
发表时间:
2010-08-20
期刊:
影响因子:
3.7
通讯作者:
Kong X
Kong X
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Chen X;Li X;Wang P;Liu Y;Zhang Z;Zhao G;Xu H;Zhu J;Qin X;Chen S;Hu L;Kong X

文献摘要

参考文献

被引文献

相似文献

Copy number variations (CNV) are important causal genetic variations for human disease; however, the lack of a statistical model has impeded the systematic testing of CNVs associated with disease in large-scale cohort. Here, we developed a novel integrated strategy to test CNV-association in genome-wide case-control studies. We converted the single-nucleotide polymorphism (SNP) signal to copy number states using a well-trained hidden Markov model. We mapped the susceptible CNV-loci through SNP site-specific testing to cope with the physiological complexity of CNVs. We also ensured the credibility of the associated CNVs through further window-based CNV-pattern clustering. Genome-wide data with seven diseases were used to test our strategy and, in total, we identified 36 new susceptible loci that are associated with CNVs for the seven diseases: 5 with bipolar disorder, 4 with coronary artery disease, 1 with Crohn's disease, 7 with hypertension, 9 with rheumatoid arthritis, 7 with type 1 diabetes and 3 with type 2 diabetes. Fifteen of these identified loci were validated through genotype-association and physiological function from previous studies, which provide further confidence for our results. Notably, the genes associated with bipolar disorder converged in the phosphoinositide/calcium signaling, a well-known affected pathway in bipolar disorder, which further supports that CNVs have impact on bipolar disorder. Our results demonstrated the effectiveness and robustness of our CNV-association analysis and provided an alternative avenue for discovering new associated loci of human diseases.
DOI: 10.1016/j.ejcb.2005.08.002
发表时间: 2006-04-01
影响因子: 6.6
作者:
Hauck, CR;Agerer, F;Schmitter, T
通讯作者: Schmitter, T
DOI: 10.1007/s00213-008-1095-x
发表时间: 2008-07-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Fedorenko, Olga;Strutz-Seebohm, Nathalie;Lang, Undine E.
通讯作者: Lang, Undine E.
DOI: 10.1176/appi.ajp.162.3.616
发表时间: 2005-03-01
影响因子: 17.7
作者:
Hahn, CG;Gomez, G;Rawson, NE
通讯作者: Rawson, NE
DOI: 10.1126/science.1101160
发表时间: 2005-03-04
期刊: SCIENCE
影响因子: 56.9
作者:
Gonzalez, E;Kulkarni, H;Ahuja, SK
通讯作者: Ahuja, SK
DOI: 10.1371/journal.pone.0003625
发表时间: 2008
期刊: PLOS ONE
影响因子: 3.7
作者:
Mudge, Joann;Miller, Neil A.;Khrebtukova, Irina;Lindquist, Ingrid E.;May, Gregory D.;Huntley, Jim J.;Luo, Shujun;Zhang, Lu;van Velkinburgh, Jennifer C.;Farmer, Andrew D.;Lewis, Sharon;Beavis, William D.;Schilkey, Faye D.;Virk, Selene M.;Black, C. Forrest;Myers, M. Kathy;Mader, Lar C.;Langley, Ray J.;Utsey, John P.;Kim, Ryan W.;Roberts, Rosalinda C.;Khalsa, Sat Kirpal;Garcia, Meredith;Ambriz-Griffith, Victoria;Harlan, Richard;Czika, Wendy;Martin, Stanton;Wolfinger, Russell D.;Perrone-Bizzozero, Nora I.;Schroth, Gary P.;Kingsmore, Stephen F.
通讯作者: Kingsmore, Stephen F.